Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma

Arthritis Rheum. 2003 Jun 15;49(3):394-8. doi: 10.1002/art.11109.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Lymphoma / complications*
  • Lymphoma / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Rituximab
  • Sjogren's Syndrome / complications*
  • Sjogren's Syndrome / diagnosis
  • Sjogren's Syndrome / drug therapy*
  • Sjogren's Syndrome / pathology
  • Tomography, Emission-Computed
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab